The age at which natural menopause occurs has remained largely stable over the past few decades, typically ranging between 45 and 55 years, with a global average of about 51 years.
The Kenya Mini Demographic and Health Survey 2025–26 reports that 10.7 per cent of women aged 30 to 49 are menopausal. The proportion rises with age, from 4.3 per cent among women aged 30 to 34 to 26.4 per cent among those aged 46 and 47, and 43.8 per cent among women aged 48 and 49.
However, Dr Justus Wambugu, a consultant gynaecologist at Aga Khan University Hospital, Nairobi, says some localised studies have indicated a declining age at menopause.
These findings have been linked to reproductive factors such as later age at first childbirth and fewer children per woman, as well as lifestyle changes, including undernutrition, cigarette smoking and excessive alcohol consumption.
“It is important to note that such evidence remains scanty and is not generalisable. Large observational population-based studies indicate that globally, there has not been a significant change in the age at which natural menopause occurs,” he says.
Dr Wambugu explains that menopause timing is influenced by genetic, biological, lifestyle and environmental factors.
“Genetics play a key role and are, as such, a strong predictor of menopause timing. Certain genetic conditions can predispose a woman to early menopause,” he explains.
Medical conditions, including endocrine and autoimmune diseases, severe chronic illnesses, some infections and cancer treatments, can also affect ovarian function and lead to early menopause.
Women in their 30s and 40s who previously had regular menstrual cycles should seek medical attention if they go for more than three consecutive months without menstruating. Those with a history of irregular periods should be concerned if they go six months without a period.
“Some may experience other symptoms of menopause, such as hot flushes, sleep disturbance and cognitive disturbances, including memory impairment. When such occurs in a woman below 40 years of age, medical evaluation is necessary,” he cautions.
“Yes,” he says, adding that it is important to distinguish genuine menopausal symptoms from other conditions, including pregnancy, thyroid disease and psychological stress.
Early symptoms may include hot flushes, persistent vaginal dryness, reduced libido, mood changes and disrupted sleep.
“When such symptoms occur in a woman in their 30s, they should be evaluated by a qualified reproductive health specialist,” he advises.
Dr Wambugu describes menopause as “one of the relatively neglected areas of healthcare provision”, despite the health challenges associated with menopause and the transition preceding it.
“Diagnostic tools may be there, but local studies have shown that there exist substantial gaps in terms of management and access to the right information in regard to menopause,” he says.
He notes that in 2025, the Ministry of Health highlighted significant gaps in healthcare workers’ training on menopause. He says more needs to be done to ensure women receive accurate information, appropriate support and access to treatment.
“Some will have very severe symptoms; others will have mild symptoms,” he explains, attributing these differences to genetics and other biological, medical and lifestyle factors.
Lifestyle changes can help manage symptoms. Regular physical activity, healthy eating, stress management, adequate sleep and avoiding individual symptom triggers can improve wellbeing. However, these measures may not be sufficient for women experiencing early menopause, severe symptoms or long-term health risks.
“Medical interventions are indicated, for instance, in cases of premature menopause, that is, before 40 years; severe hot flushes, severe loss of bone density (osteoporosis) and genitourinary symptoms such as persistent vaginal dryness,” he says.
Hormone replacement therapy (HRT) may benefit women with premature or early menopause, provided there are no contraindications. It can relieve severe hot flushes, poor sleep, mood changes and vaginal dryness, while helping slow bone loss.
However, HRT is not suitable for everyone. Women with a personal or strong family history of blood clotting conditions, breast or uterine cancer, unexplained vaginal bleeding or liver disease may face additional risks.
“Detailed assessment by the right healthcare provider is paramount before initiation of HRT,” he cautions.
Dr Wambugu warns that symptoms occurring before 40 should not be dismissed as normal. Persistent night sweats, severe hot flushes, unexplained weight loss, ongoing fatigue and sleep disturbances also warrant medical attention.
Although menstrual changes are common during perimenopause, unusually heavy bleeding, newly painful periods and pelvic pain should be investigated.
“Any vaginal bleeding occurring after 12 months without menstrual flow should always be assessed and addressed,” he adds.